Breaking News Instant updates and real-time market news.

FPRX

Five Prime

$8.40

-0.04 (-0.47%)

07:40
06/03/19
06/03
07:40
06/03/19
07:40

Five Prime downgraded to Market Perform following ASCO data at Wells Fargo

As previously reported, Wells Fargo analyst Jim Birchenough downgraded Five Prime Therapeutics to Market Perform from Outperform following review of data at ASCO for B7:H4 antibody FPA-150 in B7:H4+ patients with solid tumors including ovarian cancer. The analyst says overall response rate of 1/18 in B7:H4+ tumors was "underwhelming," with lack of clarity on dose response. Birchenough also lowered his price target on the shares to $10 from $35.

  • 04

    Jun

  • 07

    Jun

FPRX Five Prime
$8.40

-0.04 (-0.47%)

04/12/19
GUGG
04/12/19
INITIATION
Target $24
GUGG
Buy
Five Prime assumed with a Buy at Guggenheim
Guggenheim analyst Michael Schmidt assumed coverage of Five Prime Therapeutics with a Buy rating and $24 price target. Early pipeline updates in 2019 may represent potential upside while investors await data from bemarituzumab, a well- positioned gastric cancer asset, Schmidt tells investors in a research note.
05/28/19
ROTH
05/28/19
INITIATION
Target $10
ROTH
Neutral
Five Prime initiated with a Neutral at Roth Capital
Roth Capital analyst Tony Butler initiated Five Prime initiated with a Neutral and $10 price target.
05/28/19
ROTH
05/28/19
INITIATION
Target $10
ROTH
Neutral
Five Prime initiated with a Neutral at Roth Capital
Roth Capital analyst Tony Butler initiated Five Prime with a Neutral rating and a price target of $10. The analyst is positive on the company's "robust protein therapeutics platform" with additional upside potentially coming from its expected clinical updates from two early stage programs, also noting that the recent profitability efforts could also make it an "appealing M&A target". Butler warns however that "significant overhang" exists over Five Prime's lead Bemarituzumab program.
06/03/19
WELS
06/03/19
DOWNGRADE
Target $10
WELS
Market Perform
Five Prime downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo Securities analyst Jim Birchenough downgraded Five Prime Therapeutics to Market Perform from Outperform and lowered his price target for the shares to $10 from $35.

TODAY'S FREE FLY STORIES

13:25
10/15/19
10/15
13:25
10/15/19
13:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

ZM

Zoom Video

$69.34

-1.49 (-2.10%)

13:25
10/15/19
10/15
13:25
10/15/19
13:25
Conference/Events
Zoom Video to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Dec

GM

General Motors

$36.32

0.81 (2.28%)

13:23
10/15/19
10/15
13:23
10/15/19
13:23
Periodicals
GM, UAW said to have agreement on temp worker arrangement, Bloomberg reports »

GM has agreed to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LYFT

Lyft

$40.61

0.84 (2.11%)

13:21
10/15/19
10/15
13:21
10/15/19
13:21
Rumors
Rumor moving shares of Lyft »

Rumor: Lyft moves up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

  • 19

    Nov

USFD

US Foods

$39.29

-1.28 (-3.16%)

13:19
10/15/19
10/15
13:19
10/15/19
13:19
Recommendations
US Foods analyst commentary  »

US Foods chief supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 12

    Nov

COST

Costco

$298.24

0.69 (0.23%)

13:19
10/15/19
10/15
13:19
10/15/19
13:19
Downgrade
Costco rating change  »

Costco downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/15/19
10/15
13:17
10/15/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

Fox Corp.

$31.37

0.33 (1.06%)

, FOXA

Fox Corp.

$31.62

0.21 (0.67%)

13:16
10/15/19
10/15
13:16
10/15/19
13:16
Periodicals
Shari Redstone considers plan to launch Fox News rival, THR says »

As the merger between…

FOX

Fox Corp.

$31.37

0.33 (1.06%)

FOXA

Fox Corp.

$31.62

0.21 (0.67%)

CBS

CBS

$38.17

0.24 (0.63%)

CBS.A

$41.77

(0.00%)

VIA

Viacom

$25.28

0.015 (0.06%)

VIAB

Viacom

$22.87

0.145 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/15/19
10/15
13:16
10/15/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

13:12
10/15/19
10/15
13:12
10/15/19
13:12
Periodicals
Breaking Periodicals news story on We Company »

WeWork loses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$57.92

0.08 (0.14%)

, RDS.B

Royal Dutch Shell

$58.44

0.14 (0.24%)

13:06
10/15/19
10/15
13:06
10/15/19
13:06
Periodicals
Shell CEO still sees big opportunties for investors in oil and gas, Reuters says »

Royal Dutch Shell CEO Ben…

RDS.A

Royal Dutch Shell

$57.92

0.08 (0.14%)

RDS.B

Royal Dutch Shell

$58.44

0.14 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$6.56

0.17 (2.66%)

13:05
10/15/19
10/15
13:05
10/15/19
13:05
Options
Viking Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNPOF

Canopy Rivers

$0.00

(0.00%)

13:02
10/15/19
10/15
13:02
10/15/19
13:02
Hot Stocks
Canopy Rivers portfolio company receives Health Canada license amendment »

Canopy Rivers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$12.26

0.28 (2.34%)

13:02
10/15/19
10/15
13:02
10/15/19
13:02
Periodicals
Credit Suisse eyes adding more advisers to billionaire clients, Bloomberg says »

Credit Suisse is seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CHGG

Chegg

$32.76

0.12 (0.37%)

13:02
10/15/19
10/15
13:02
10/15/19
13:02
Hot Stocks
Law firm initiates investigation into data breach at Chegg »

Federman & Sherwood,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

CRWD

Crowdstrike

$55.38

0.87 (1.60%)

13:00
10/15/19
10/15
13:00
10/15/19
13:00
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

13:00
10/15/19
10/15
13:00
10/15/19
13:00
General news
Treasury Action: yields continue to rise »

Treasury Action: yields…

FB

Facebook

$189.25

5.96 (3.25%)

, V

Visa

$178.66

1.31 (0.74%)

12:58
10/15/19
10/15
12:58
10/15/19
12:58
Periodicals
Facebook advances Libra amid backer mutiny, Business Insider says »

Facebook (FB) took…

FB

Facebook

$189.25

5.96 (3.25%)

V

Visa

$178.66

1.31 (0.74%)

MA

MasterCard

$278.77

2.29 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

12:55
10/15/19
10/15
12:55
10/15/19
12:55
Conference/Events
Morgan Stanley analysts to hold an analyst/industry conference call »

Executive Director of…

APHA

Aphria

$5.40

1.07 (24.71%)

12:51
10/15/19
10/15
12:51
10/15/19
12:51
Recommendations
Aphria analyst commentary  »

Seaport Global says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

GOOG

Alphabet

$1,240.28

22.05 (1.81%)

, GOOGL

Alphabet Class A

$1,240.59

22.98 (1.89%)

12:44
10/15/19
10/15
12:44
10/15/19
12:44
Hot Stocks
Google Stadia launches on November 19th »

In a tweet, the Google…

GOOG

Alphabet

$1,240.28

22.05 (1.81%)

GOOGL

Alphabet Class A

$1,240.59

22.98 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

GOOG

Alphabet

$1,240.62

22.39 (1.84%)

, GOOGL

Alphabet Class A

$1,241.32

23.71 (1.95%)

12:40
10/15/19
10/15
12:40
10/15/19
12:40
Hot Stocks
Google announces Nest Wifi system »

Alphabet's Google…

GOOG

Alphabet

$1,240.62

22.39 (1.84%)

GOOGL

Alphabet Class A

$1,241.32

23.71 (1.95%)

TGT

Target

$111.99

0.85 (0.76%)

BBY

Best Buy

$68.65

-0.055 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

GOOG

Alphabet

$1,240.95

22.72 (1.87%)

, GOOGL

Alphabet Class A

$1,241.95

24.34 (2.00%)

12:38
10/15/19
10/15
12:38
10/15/19
12:38
Hot Stocks
Google introduces Google Pixel Buds »

Alphabet's Google…

GOOG

Alphabet

$1,240.95

22.72 (1.87%)

GOOGL

Alphabet Class A

$1,241.95

24.34 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

UNH

UnitedHealth

$235.51

15.19 (6.89%)

, CNC

Centene

$45.39

1.49 (3.39%)

12:37
10/15/19
10/15
12:37
10/15/19
12:37
Hot Stocks
Health insurance providers move higher after UnitedHealth Q3 results »

Health insurance…

UNH

UnitedHealth

$235.51

15.19 (6.89%)

CNC

Centene

$45.39

1.49 (3.39%)

ANTM

Anthem

$249.46

14.73 (6.28%)

HUM

Humana

$275.49

11.53 (4.37%)

MOH

Molina Healthcare

$117.98

5.495 (4.89%)

CI

Cigna

$159.78

8.165 (5.39%)

WCG

WellCare

$268.48

5.44 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 07

    Nov

  • 13

    Nov

  • 14

    Nov

TGT

Target

$112.03

0.89 (0.80%)

, BBY

Best Buy

$68.72

0.015 (0.02%)

12:36
10/15/19
10/15
12:36
10/15/19
12:36
Hot Stocks
Google announces next-generation Nest Mini »

Alphabet's Google…

TGT

Target

$112.03

0.89 (0.80%)

BBY

Best Buy

$68.72

0.015 (0.02%)

GOOGL

Alphabet Class A

$1,243.00

25.39 (2.09%)

GOOG

Alphabet

$1,242.22

23.99 (1.97%)

WMT

Walmart

$119.12

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.